EXOZ eXoZymes Inc.
$6.30▲ +2.13%
Healthcare
Other
After hours
$6.41▲ +1.64%
Sep 11, 7:30 PM ET
Volume 4.5K
Avg Volume (10D) 5.0K
Key Metrics & Fundamentals
Market Cap
$58.49M
P/E Ratio
–
Div Yield
–%
52W Range
4.35 - 18.40
% vs 50 MA
2.61%
% vs 200 MA
-30.81%
RSI-14
47.5
MACD Histogram
-0.1000
Beta (1Y vs SPY)
1.18
Free Cash Flow
-$1.64M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.05M
COGS
–
Operating Exp
$2.95M
Operating Income
-$2.95M
EBIT
-$2.95M
Pretax Income
-$2.88M
Net Income
-$2.88M
EPS (Diluted)
-0.33
Price & Volume History
Loading chart…
Recent News
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
ACCESS Newswire · Sep 8, 2026 2:20 PM
Investor Summit | MicroCap Opportunities to Watch - August 26
ACCESS Newswire · Aug 24, 2026 12:45 PM
EXoZymes Inc (EXOZ) (Q2 2026) Earnings Call Highlights: Strategic Pivot and 10x Productivity ...
GuruFocus.com · Aug 22, 2026 1:03 AM
eXoZymes Q2 Earnings Call Highlights
MarketBeat · Aug 20, 2026 11:02 PM
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today
ACCESS Newswire · Aug 20, 2026 8:10 PM
eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets
ACCESS Newswire · Aug 18, 2026 8:30 PM
MDB Capital Holdings LLC (MDBH) (Q2 2026) Earnings Call Highlights: Strategic Pivots and Asset ...
GuruFocus.com · Aug 18, 2026 1:04 AM
MDB Capital Holdings Provides Second Quarter 2026 Update
GlobeNewswire · Aug 13, 2026 8:05 PM
eXoZymes to Host Second Quarter 2026 Update Conference Call on Thursday, August 20, 2026
ACCESS Newswire · Aug 11, 2026 8:10 PM
eXoZymes Selected for DoE's Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free Biomanufacturing
ACCESS Newswire · Jul 23, 2026 8:15 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See EXOZ's money flow as a full page
Social Sentiment
No Reddit posts found for EXOZ.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.